Genes involved in the regulation of synaptic vesicle function are potential candidates for the development of psychiatric disorders. In addition to experimental and theoretical considerations, a number of genes involved in synaptic vesicle function map to regions of the genome that have been linked to bipolar disorder (BPD) and schizophrenia (SZ). One is synaptojanin 1 (SYNJ1) which maps to 21q22.2, a chromosomal region that has been linked to BPD in a subset of families in several studies. Synaptojanin 1 is an inositol 5-phosphatase that has an important role in synaptic vesicle endocytosis. Mutation screening of 32 exons, intron-exon junctions, and 839 bases of 5Ј-flanking DNA resulted in the identification of 11 mutations of which four were very common and seven were very rare. Of the 11 mutations identified, several may have functional significance including two coding variants, two that may affect the binding of a transcription factor, and two that involve known splicing regulatory domains. Five bipolar patients out of 149 analyzed were found who have one of the four rare variants that were most likely to have functional significance compared with 0/148 controls. The allele frequencies for three of the four common variants were very similar in bipolar patients and controls. A slight difference in allele frequency was found for an interesting mutation we detected in intron 12 in which two non-adjacent thymidine residues are deleted in a poly-AT tract located near the exon 12 splice donor site ( 2 = 2.45, P = 0.12, 2-tailed). Although we failed to unequivocally identify a specific SYNJ1 allele that could be responsible for putative chromosome 21q22-linked BPD, several interesting variants were found to be increased in bipolar subjects and should be further investigated. Molecular Psychiatry (2001) 6, 387-395.
Introduction
Genes involved in the regulation of synaptic vesicle function are good candidates to consider for BPD susceptibility. This idea is based on several observations. First, Ca 2+ and phosphoinositides, which are critical mediators of synaptic vesicle function, are targets for some of the drugs used to treat BPD. 1 Second, depletion of vesicle catecholamines by reserpine may cause depression, especially in patients with underlying mood disorders. 2 Third, amphetamine, which induces behavioral changes similar to those found in SZ and in mania, causes the redistribution of catecholamines from vesicles to cytosol. 3 Fourth, deletion of the gene encoding the SNARE protein SNAP-25 in the coloboma mouse strain causes behavioral alterations that mimic those found in patients with attention deficit hyperactivity disorder (ADHD). 4 The clini-cal features of ADHD overlap with those found in mania and hypomania. Fifth, altered expression of the synaptic proteins SNAP-25, synaptophysin, and complexins I and II, have been found in the brains of schizophrenics and bipolar individuals. [5] [6] [7] [8] [9] Finally, a number of genes encoding homologs of SNARE and vesicle proteins, and their regulators, map to regions of the genome that are suspected to harbor BPD and SZ susceptibility genes. SNAP29, RAB36, phosphatidylinositol 4-kinase (Pl4K), synapsin III and synaptogyrin 1 map to chromosome 22q11-13, [10] [11] [12] [13] [14] [15] [16] synapsin I and synaptophysin map to Xp11, 17 SYBL1 maps to Xq28, 18 syntaxin 7 maps to 6q21 [19] [20] [21] and SYNJ1, which encodes synaptojanin, a phosphatase enriched in presynaptic terminals, maps to 21q22.2. [22] [23] [24] [25] [26] [27] [28] Phosphoinositides are important regulators of vesicle exocytosis and endocytosis. 29 The endocytic proteins synaptojanin, dynamin 1 and amphiphysin, and synaptotagmin, a synaptic vesicle protein involved in exocytosis through its role as a Ca 2+ sensor, all bind phosphoinositides. [30] [31] [32] [33] [34] Synaptojanin regulates endocytosis by dephosphorylating soluble and lipidic phosphoinositides at the 5Ј position of the inositol ring. Its targets include phosphatidylinositol 4,5-bisphosphate (Pl(4,5)P 2 ) and phosphatidylinositol 3,4,5-trisphos-Molecular Psychiatry phate (Pl(3,4,5)P 3 . [29] [30] [31] [32] The dephosphorylation of Pl(4,5)P 2 by synaptojanin is a critical step in the uncoating of clathrin from endocytic vesicles.
The SYNJ1 gene encodes 170-kDa and 145-kDa synaptojanin isoforms that are generated by alternative splicing; synaptojanin-170 is expressed at low concentrations in many tissues and fetal brain whereas synaptojanin-145 is primarily found in nerve terminals. [33] [34] [35] The SYNJ1 gene encodes three distinct functional domains. The central portion encodes the inositol 5-phosphatase activity. The 5Ј-region is homologous to the cytosolic portion of the yeast Sac1 protein, which has been implicated in the regulation of vesicular traffic. The Sac1-like homology has been shown to have an intrinsic polyphosphoinositide phosphatase activity separate from that encoded by the central 5-phosphatase domain. 36, 37 The 3Ј end encodes a proline-rich region that is involved in binding synaptojanin to amphiphysin and other proteins found on endocytic vesicles. 33, 34, 37, 38 Based on its role in vesicle recycling, as well as its location on 21q22.2, a region of the genome mapped in a subset of families with BPD, we viewed SYNJ1 as a credible candidate gene for BPD.
Methods

Subjects
Patients with BPD were diagnosed on the basis of either a SADS-L interview or by unstructured clinical interview modified from SADS-L that yielded diagnostic information enabling the diagnosis of BPD using RDC criteria. 39, 40 Patients with either bipolar disorder I (BPI) (n = 95) or bipolar disorder II (BPII) (n = 54) were included in the study. The patients were recruited from clinics and private practices affiliated with the Albert Einstein College of Medicine. Forty-three subjects were unrelated patients with BPI obtained from the Coriell Institute in conjunction with the The National Institutes of Mental Health Bipolar Genetics Initiative. Patients signed an informed consent approved by the local Committee on Clinical Investigation. Control subjects were students, anonymous blood bank donors, anonymous DNA samples obtained from liver biopsies in consenting patients undergoing abdominal surgery, and hospital, medical school, and clinic staff. No formal testing procedure was used to screen controls for underlying psychiatric illness. All patients and controls were Caucasian. There were 79 female and 70 male controls (mean age 45.5 ± 15.2 female, 44.3 ± 15.7 male), and 83 female and 66 male patients with BPD (mean age 40.4 ± 10.8 female, 41.0 ± 11.7 male).
Mutation detection and genotyping
DNA was extracted from whole blood or buccal smears using a Puregene DNA isolation kit (Gentra Systems, Minneapolis, MN, USA) or by standard phenol extraction methods. SYNJ1 exons and intron-exon junctions were mapped by comparing the cDNA sequence with chromosome 21 genomic DNA (GenBank accession numbers AF009039, AP000181, AP000105, AP000182, and AP000277). Primers were derived from intron sequences and were designed to amplify exons and intron-exon junctions. Overlapping primers were used to amplify the 5Ј-flanking region. The primers used in this study are shown in Table 1 . The SYNJ1 gene is cloned in the opposite orientation in all of the genomic clones in GenBank. However, the polymorphisms reported in this study are reported from the perspective of the sense strand.
PCR-amplified genomic DNA fragments were screened for polymorphisms using a modification of the single strand conformation polymorphism (SSCP) PCR primers are derived from intron sequences and flank the exon number shown with 5Ј to 3Ј direction from left to right. Restriction enyzmes were used for exon primer sets 4 (EcoR1), 5 (Cac81), 21 (Sau96l) and 31 (Bsu361) to reduce size of PCR product for SSCP. Size of PCR product in base pairs shown at right.
analysis procedure originally described by Orita et al. 41 Forty-five DNA samples obtained from unrelated patients with BPI were used in the screening. PCR was performed in a 20-l reaction volume containing 50 ng genomic DNA, a mixture of all four nucleotides (final concentration 0.2 mM for each), 1 × reaction buffer, 20 pM of each primer and 1.25 U taq polymerase (Gibco-BRL, Grand Island, NY, USA). A list of all the primers used in this study and the size of the PCR product are shown in Table 1 . For mutation screening by SSCP using a minigel system (Novex, Santa Clarita, CA, USA), 5 l of PCR product was denatured for 5 min at 95°C with 20 l of denaturing mix (90% formamide, 0.5 × TBE, 0.02 N NaOH, 0.1% xylene cyanol, 0.1% bromocresol purple) and then quenched on ice. The sample was loaded onto 4-20% non-denaturing acrylamide minigels (1 mm thick) containing 4% glycerol in 1.25 × TBE buffer. A control sample containing nondenatured DNA was used to identify bands that corresponded to annealed double stranded DNA. The samples were subjected to electrophoresis at 200 V at 4°C until the xylene cyanol dye reached the bottom of the gel. The temperature of the gel was maintained using a circulating, temperature controlled water bath. Following electrophoresis, the gel was stained with SYBR II dye according to the manufacturer's instructions (Novex) and photographed under UV light. The minigel system was generally used for PCR products smaller than 225 nucleotides. For larger samples, between 225-300 nucleotides, SSCP screening was performed using a standard long sequencing apparatus with radio-labelled PCR products. PCR products were labelled by reducing the dCTP final concentration from 200 M to 100 M and adding 0.25 l 32 P-dCTP (3000 Ci mM
−1
). For most PCR products larger than 300 nucleotides, radio-labelled PCR products were digested with a convenient restriction endonuclease to generate smaller fragments. The exception was the exon 28/29 primer set which generates a 370-bp PCR product that contains two common polymorphisms and two rare mutations that could all be resolved without restriction digestion. The samples were denatured and subjected to electrophoresis at 4°C through long 5% acrylamide gels containing 5% glycerol until the xylene cyanol tracking dye migrated a distance of 30-40 cm. Gels were dried and exposed to X-ray film at −70°C with intensifying screens for approximately 18 h.
DNA samples with SSCP band shifts were subjected to DNA sequence analysis. This was performed on purified PCR templates using fluorescent-labelled dideoxy sequencing and an Applied Biosystems model 377 sequencer. prior to sequencing, the PCR products were purified using a commercially available column to separate unused primers and nucleotides from the PCR reaction (Qiagen, Valencia, CA, USA). The sequencing data were compared with the available published sequence information using BLAST. Both DNA strands were sequenced.
All genotypes were performed by SSCP and scored independently by two investigators (TS and HL). Representative radiolabeled SSCP gels used for genotyping Molecular Psychiatry the four common polymorphisms are shown in Figure 1a . Positive controls for each allele were included on each gel used for genotyping. When there were discrepancies, the gels were reviewed together and if no agreement could be made, the analysis was repeated.
Computer analysis
The BLAST network at the National Center for Biotechnology Information was used to analyze DNA sequences. The program Matlnspector V2.250 was used to identify potential protein-DNA binding sites. 42 
Statistical analysis
The association to the SYNJ1 SNPs was tested using the 
Results
The 21q22-linked SYNJ1 gene spans more than 70 kilobases (kb) and contains more than 30 exons. The brain-specific 145-kD isoform and the 170-kD isoform are generated by an alternative splice at exon 32. The brain-specific exon 32 contains an inframe stop codon that results in a relatively short proline-rich C-terminal end. To generate the 170-kD isoform, there is an alternative splice in which the brain-specific exon is bypassed and a large 3Ј exon is incorporated. This results in a protein with a different proline-rich C-terminal end containing 266 additional amino acids. The proline-rich terminus contains several SH3 domainbinding sites which are involved in target specificity. 34 The Sac1 and inositol 5-phosphatase domains are similar in both the brain-specific and ubiquitous forms. However, alternative splicing at other exons may create additional diversity in the catalytic domains. The translation initiation site is found in exon 2. In this study, the 32 exons that encode the brain-specific isoform (GenBank accession number AF009039), and 839 bp of 5Ј-flanking DNA, were screened for mutations using SSCP analysis (see Table 1 for list of primers). The DNA samples used in the initial screening were derived from 45 unrelated patients with BPI disorder.
A total of 11 mutations were detected in the SSCP screening. Of these, seven were quite rare and will be described first (Table 2) . One rare variant was found in the 5Ј-flanking region, 1898 nucleotides upstream from the translation start site (−1898TϾC). The mutation was found in only one out of 140 bipolar subjects and zero out of 148 controls. Although the functional role of this mutation is not known at this time, it occurs in a putative E-box consensus, a binding site for many basic helix-loop-helix (bHLH) proteins (Figure 1b) . 43 Using the exon 1 primer set, a rare CϾA transversion was found in a GC-rich intron sequence 58 nucleotides Figure 1 (a) SSCP. Representative autoradiograms of SSCP gels used to genotype the common polymorphisms in exon 8, IVS12, IVS28 and IVS29. Band patterns for homozygotes and heterozygotes shown. Both the IVS28 and IVS29 polymorphisms were identified on the same SSCP gel. The genotypes for these are shown at the top and bottom of the SSCP gel, while the haplotypes generated by combining the IVS28 and IVS29 alleles are shown at right. The haplotype generated by IVS28G and IVS29T was not detected. All genotypes were confirmed by sequencing. Autoradiograms shown for each polymorphism taken from same gel, although lanes shown were not necessarily contiguous. (b) Sequence of selected SYNJ1 mutations. Putative promoter mutation (−1898TϾC) at E-box binding site consensus (CANNTG) in bold type. IVS1+58CϾA mutation in GC-rich region (shown in bold) alters one of the two putative Sp1 consensus sequences (underlined). IVS6−49GϾA mutation showing putative native breakpoint region underlined; the mutation leads to a 6/7 match (bold type) for branchpoint consensus YNYYRAY (Y = pyrimidine, R = purine, N = any nucleotide, A = adenine). PPT is double underlined. Bottom of figure shows IVS12+15delT,+17delT. The poly AT-tract is underlined and the deleted thymidine residues at positions 15 and 17 relative to splice junction are shown in bold type.
from the intron 1 (intervening sequence 1 or IVS1) splice donor site (IVS1 + 58CϾA). This mutation was found in only one patient with BPD out of 143 unrelated subjects analyzed and no controls out of 148 analyzed. There is an 18/20 and a 52/60 GC stretch in the wild-type sequence and 17/20 and 51/60 in the mutant (Figure 1b) . The mutation occurs in a consensus binding site for the transcription factor Sp1. This patient had one sibling with BPD who also inherited the mutation. The siblings, obtained from the The National Institutes of Mental Health Bipolar Genetics Initiative DNA repository, are the offspring of parents who both have psychiatric illnesses.
Two rare mutations were found with the exon 7 primer set. One is an AϾG transition in intron 7, 43 nucleotides from the exon 7 splice donor site (IVS7+43AϾG). This SNP was found in six out of 149 unrelated bipolar patients and five out of 148 controls. Table 3  Table 3  substitution  exon 12 IVS12+15delT, +17delT AT-rich region at splice donor Table 3  Table 3 Table 3  Table 3  exon 28/29  IVS29+14CϾT 14 bp from splice donor Table 3  Table 3 Summary of mutations. Frequencies only shown for rare alleles. See Table 3 for analysis of common variants.
One of the six bipolar patients had a sibling with BPD available for analysis who was found to also have inherited the mutation. Another proband has two siblings with BPD only one of whom inherited this mutation. The intron 7 SNP does not appear to alter the sequence of any known functional domain. The other mutation detected with the exon 7 primer set was found in intron 6, 49 bp from splice acceptor site (IVS6−49GϾA). This was found in two patients with BPD and no controls. The mutation results in a partial match (6/7) to a consensus branchpoint sequence 19 nucleotides upstream from the putative native branchpoint sequence in this intron (Figure 1b) . The branchpoint consensus (YNYYRAY, where Y = pyrimidine, R = purine, N = any nucleotide, A = adenine) is important in intron excision at the 3Ј splice acceptor site. 44 The putative natural branchpoint site is also a 6/7 match to the consensus. Whether the −49 mutation results in the creation of a 'cryptic' branchpoint site and influences splicing remains to be determined.
Two SYNJ1 coding variants were found in exon 8, located in the Sac1 homology, at codon 286 (TTTϾCTT, pheϾleu, F286L) and codon 295 (AAA−ϾAGA, lysϾarg, K295R). Although both are conservative amino acid changes, pheϾleu and lysϾarg substitutions have been found that alter protein function. [45] [46] [47] The F286L variant was only found in one out of 147 bipolar subjects and zero out of 148 control subjects. This individual had two siblings with BPD but neither one inherited this mutation. The analysis of K295R, a very common variant found at a frequency of 0.32 is discussed later in this section.
Two common and two rare mutations were found when the exon 28/29 primer set was analyzed. The two rare mutations are a CϾA transversion and a TϾG transversion 33 bp and 29 bp, respectively, 5Ј to the exon 28 splice acceptor site (IVS27−33CϾA, and IVS27−29TϾG). These were found between the putaMolecular Psychiatry tive branchpoint consensus and the PPT in the 3Ј end of intron 27 and are not expected to affect these regulatory domains. Only one control out of 139 analyzed and one bipolar patient out of 145 analyzed inherited the −33 mutation while two controls and no patients with BPD inherited the −29 mutation.
The compilation of all the rare alleles is shown in Table 2 . Eight rare alleles were found in 148 control subjects compared with 12 out of 149 bipolar subjects. However, when the rare mutations are sub-divided into those more likely to have functional significance, based on whether or not the mutation occurs in a known regulatory region, including −1898TϾC, IVS1+58CϾA, IVS6−49GϾA and F286L, there were five rare alleles found in patients with BPD and no controls (Table 2) . However, the number is too small for a valid statistical comparison.
Four of the mutations we detected were very common thereby allowing for a more valid comparison between bipolar and control subjects using a case control analysis. One is the exon 8 K295R variant for which an allele frequency of 0.32 was found in both controls and bipolar patients (Table 3, The two common SNPs detected using the exon 28/29 primer set included a GϾT transversion in a PPT at the intron 28 splice acceptor site, seven nucleotides from exon 29 (IVS28−7GϾT), and a CϾT transition in intron 29, 14 nucleotides from the exon 29 splice donor (IVS29+14CϾT). Since PPTs bind to a number of proteins, including heterogeneous ribonucleoprotein (hnRNP) and polypyrimidine tract binding protein (PTB), and are important in removing the intron from pre-mRNA and in alternative splicing, we viewed the IVS28, −7GϾT SNP, which increases the number of pyrimidines in the PPT, as a possibly functional mutation. [48] [49] [50] However, similar to the K295R variant, the frequency of both the IVS28, −7GϾT and IVS29, Genotypes and alleles for the four common polymorphisms detected in the SYNJ1 gene. Number of subjects with each genotype and number of alleles are shown with frequency in parenthesis. There were no significant differences in the allele and genotype distributions except for a trend towards association in the allele distribution for intron 12 mutation ( 2 = 2.45, P = 0.12, 1 df, odds ratio = 95% CI = 0.93-1.79).
+14CϾT SNPs and the distribution of alleles and genotypes were very similar in controls and bipolar subjects (Table 3, The only SYNJ1 mutation that showed a nominal difference between bipolar subjects and controls was the one detected using the exon 12 primer set. This is an interesting polymorphism in a poly AT tract that begins 11 nucleotides downstream from the exon 12-intron 12 border. The poly AT tract contains either 25/26 (allele 1) or 23/24 (allele 2) adenine or thymidine nucleotides. Allele 2 is generated by a deletion of the fifth and seventh thymidine residues in the poly AT tract, 15 and 17 nucleotides downstream from the 5Ј splice donor site (IVS12+15delT, +17delT) (Figure 1b) . In contrast to the marked similarity in the allele frequencies between bipolar subjects and controls for all of the other common polymorphisms, there was a slight increase in allele 2 in bipolar subjects that fell short of statistical significance (Table 3, There was a 27% increase in the number of bipolar subjects homozygous for allele 2, compared with controls, without any difference in the percentage of heterozygotes. Consequently, if this allele proves to play any role in the development of BPD in a subset of patients, its pattern of inheritance will be as an autosomal recessive trait.
Haplotypes were generated using the K295R, IVS12+15delT,+17delT, and IVS28−7TϾG polymorphisms. There was no significant departure from Hardy-Weinberg equilibrium for any of the 36 potential genotypes generated from the combined alleles. A borderline significant result was found with a haplotype generated from IVS12 allele 2, and exon 8 allele G (dominant disease model: P = 0.075 for 80% penetrance and 0.072 for 10% penetrance).
Discussion
Based on theoretical considerations and some experimental findings, we have recently begun to analyze genes involved in synaptic vesicle function as candidates for BPD and SZ. In a previous study, an SNP in the intron 7 PPT of the SYBL1 gene, a synaptobrevin analog that maps to Xq28, was found at a slightly higher frequency in males with BPD compared with controls. 18 In another study (in press), we identified a mutation in the promoter of the SNAP29 gene that was associated with SZ. SNAP29, a member of the SNAP25 family of genes, maps to 22q11 in a region deleted in approximately 70% of patients with velo cardio facial syndrome (VCFS), a congenital disorder associated with a high prevalence of psychiatric disorders including BPD and SZ. 13, 16, 51 Considering the high false positive rate using the case control design, the findings with SYBL1 and SNAP29 should be viewed as very preliminary. In a recent analysis of the chromosome 22-linked synapsin III gene in schizophrenics, no disease-causing mutations were found. 52 In the study reported here, we have extended our investigation of genes involved in synaptic vesicle function by analyzing SYNJ1, which encodes an inositol 5-phosphatase that plays a critical role in the endocytic phase of the synaptic vesicle recycling pathway. Studies in mouse knockouts show that SYNJ1 is needed for normal neuronal function. Homozygous deletion in mice results in the accumulation of (PI(4,5)P 2 ) and a defect in endocytosis with clathrincoated vesicles accumulating in the inactive zone. 31 Although basal glutamatergic transmission is not impaired, following a train of stimuli intended to make the regeneration of active vesicles rate limiting, there is a prolonged impairment of transmission caused by a decrease in the number of vesicles capable of returning to the active zone for exocytosis. Homo-zygous deletion of Synj1 is lethal and no studies have been reported in heterozygotes.
SYNJ1 maps to chromosome 21q22.2 and evidence for linkage to this region in a subset of families with BPD has been provided in several studies. [22] [23] [24] [25] [26] [27] [28] 53 Straub et al 24 initially identified markers on 21q22 linked to BPD, using the affected pedigree member method of analysis, with the most significant result obtained for a marker in the PFKL locus on 21q22.3, which is approximately 11.6 million nucleotides telomeric to SYNJ1 (Figure 2) . 23, 24 A positive lod score in the same region was also found by Gurling et al, 53 and Smyth et al. 27 In the NIMH bipolar initiative consortium, DeteraWadleigh et al 26 identified a number of markers over a broad range on 21q22, centromeric to PFKL where excess allele sharing was detected. The markers that had the most significant P-values in their affected sib pair (ASP) analysis were D21S1254, D21S65, D21S1252 and D21S1440, which are all within 5 million nucleotides telomeric to SYNJ1. The most significant result in their ASP analysis using an affected model that included recurrent unipolar depression, as well as BPD, was obtained for a set of markers that also included D22S1270, which is 2.4 million nucleotides centromeric to SYNJ1. Since non-parametric methods of linkage can only provide a rough estimate to the map position of a trait, the relative proximity of SYNJ1 to the linked markers suggests that it can be considered a feasible candidate gene for 21q22-linked BPD. Several negative results have also been reported for this region, suggesting the possibility of genetic heterogeneity. 54, 55 In our screening of the SYNJ1 gene, several alleles that may be functionally significant, including two coding variants and several intron and promoter mutations occurring in putative regulatory regions, were identified. Of these, only the common exon 8 variant (K295R) and IVS28−7GϾT, which occurs in a PPT, were found in a sufficient number of subjects for a valid comparison using the case control method. The allele frequencies for these polymorphisms, as well as another SNP, IVS29+14CϾT, which does not appear to have functional significance, were very similar in both bipolar and control groups.
Among the rare SNPs, several appear to be of interest based on the possibility that they may have functional significance. These include IVS1+58CϾA, which changes an apparent Sp1 consensus sequence, IVS6−49GϾA, which may create a cryptic breakpoint consensus, the coding variant F286L, and the promoter Molecular Psychiatry mutation −1898TϾC, which occurs in a putative E-box domain. Overall, five bipolar patients and no controls were found to have one of these mutations. The possibility that F286L is relevant to BPD is diminished by its absence in the proband's two bipolar siblings. However, any potential functional allele should not be immediately ruled out as a candidate in view of the high frequency of assortative mating and oligogenic inheritance associated with BPD.
The only common polymorphism that showed some difference in allele frequency between controls and bipolar patients was the intron 12 variant in which there was a 27% increase in homozygotes for allele 2 in bipolar subjects compared with controls. However, population stratification could account for this small difference.
The intron 12 variant is caused by the deletion of two non-adjacent thymidine residues in an AT-rich region near the exon 12 splice donor site. The functional significance of the AT tract and the effect of the deletion polymorphism is not known at this time. However, considering that 'AT' and 'AU' rich regions are known to bind homeotic proteins, act as enhancers, and affect mRNA stability, functional significance is a distinct possibility. [56] [57] [58] [59] Whether or not the poly AT(AU) tract in intron 12 and the different allelic variants we identified have an effect on SYNJ1 gene expression remains to be determined.
A limitation of our study is that the SSCP method used in our mutation screening may fail to detect 10-20% of polymorphisms. Also, we have not yet analyzed the large terminal exon that encodes the 170-kd isoform, which is expressed ubiquitously. In addition, there may be additional regulatory regions, other than the 5Ј-promoter region, that may harbor functionally significant mutations. Intron 1, for example, is very GCrich and may contain DNA elements that regulate gene expression. Considering the identification of a rare mutation that may affect the binding of a transcription factor, found in a single bipolar subject and an affected sibling, intron 1 deserves a more thorough analysis.
Although the results of this study are marginal, with the findings of a modest increase in the intron 12 deletion variant, and an increase in rare alleles that may have functional significance, the SYNJ1 gene warrants further investigation as a candidate for 21q22-linked BPD.
